Global /United States /Healthcare /Medical Devices /EW
chevron_leftBack
Edwards Lifesciences Corp. logo

Edwards Lifesciences Corp.

EW
NYSE: EW Delayed
81.22USD -1.3%
As of 8 July 2026, Edwards Lifesciences Corp. has a market cap of $46.83B USD, ranking #528 globally and #243 in the United States. It ranks #44 in the Healthcare sector, and #11 in the Medical Devices industry.
Global Rank
528
1d: +1
1w: +2
1m: -
Country Rank
243
1d: 0
1w: +5
1m: -
Sector Rank
44
1d: 0
1w: 0
1m: -
Industry Rank
11
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$46.83BUSD
Enterprise Value
$43.3BUSD
Revenue (TTM)
$6.3BUSD
EBITDA (TTM)
$1.9BUSD
Net Income (TTM)
$1.1BUSD
EBITDA Margin
30%
Profit Margin
17%
PE Ratio
44.6
Forward PE
26.9
PS Ratio
7.4
PB Ratio
4.6
EV/EBITDA
22.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Bernard Zovighian open_in_new
Employees
16,000
Founded
1958
IPO
27 Mar 2000
Website
edwards.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.3% -0.4% 2.4% -0.8% -1.2% 7.5%

News

Loading...

EW Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
EW
Edwards Lifesciences Corp
ISIN: US28176E1082
Shares Out.:
575.8M1 Shares Float: 568.478M2
TV:
SA:
YF:
EW
GF:
NQ:
EW
BA:
EW
MS:
81.22 USD
SIX Swiss Exchange
MIC: XSWX
EW.USD
Edwards Lifesciences Corp
ISIN: US28176E1082
Shares Out.:
580.8M1 Shares Float: 572.661M2
TV:
SA:
YF:
GF:
BA:
MS:
86.42 USD
Borsa Italiana
MIC: XMIL
1EW
Edwards Lifesciences Corp
ISIN: US28176E1082
TV:
SA:
YF:
GF:
BA:
1EW
MS:
72.16 EUR
Show all 8 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Edwards Lifesciences Corp.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
270%
25.8
$160.73B
243%
56.7
$159.07B
240%
25.6
DHR
$126.55B
170%
34.7
SYK
$120.69B
158%
38.3
$84.93B
81%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
118%
22.2
$96.29B
84.32B EUR
106%
36.7
7741
$60.71B
9.83T JPY
30%
40.0
$44.92B
39.34B EUR
-4.1%
18.7
ALC
$35.9B
28.99B CHF
-23%
37.9
$29.97B
203.66B CNY
-36%
26.0
chevron_leftBack